Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens by Normand, Sylvain et al.
ARTICLE
Proteasomal degradation of NOD2 by NLRP12 in
monocytes promotes bacterial tolerance and
colonization by enteropathogens
Sylvain Normand1, Nadine Waldschmitt1,2, Andreas Neerincx3, Ruben Julio Martinez-Torres4, Camille Chauvin1,
Aurélie Couturier-Maillard1, Olivier Boulard1, Laetitia Cobret5,6, Fawaz Awad5,6, Ludovic Huot1,
Andre Ribeiro-Ribeiro4, Katja Lautz7, Richard Ruez1, Myriam Delacre1, Clovis Bondu1, Martin Guilliams 8,9,
Charlotte Scott8,9, Anthony Segal4, Serge Amselem5,6, David Hot 1, Sonia Karabina5,6, Erwin Bohn10,
Bernhard Ryffel11, Lionel F. Poulin1, Thomas A. Kufer 12 & Mathias Chamaillard1
Mutations in the nucleotide-binding oligomerization domain protein 12 (NLRP12) cause recurrent
episodes of serosal inﬂammation. Here we show that NLRP12 efﬁciently sequesters HSP90 and
promotes K48-linked ubiquitination and degradation of NOD2 in response to bacterial muramyl
dipeptide (MDP). This interaction is mediated by the linker-region proximal to the nucleotide-
binding domain of NLRP12. Consequently, the disease-causing NLRP12 R284X mutation fails to
repress MDP-induced NF-κB and subsequent activity of the JAK/STAT signaling pathway. While
NLRP12 deﬁciency renders septic mice highly susceptible towards MDP, a sustained sensing of
MDP through NOD2 is observed among monocytes lacking NLRP12. This loss of tolerance in
monocytes results in greater colonization resistance towards Citrobacter rodentium. Our data show
that this is a consequence of NOD2-dependent accumulation of inﬂammatory mononuclear cells
that correlates with induction of interferon-stimulated genes. Our study unveils a relevant process
of tolerance towards the gut microbiota that is exploited by an attaching/effacing enteric
pathogen.
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Mutations of the nucleotide-binding oligomerizationdomain protein 12 (NLRP12) are causing a familialcold-induced auto-inﬂammatory syndrome (referred as
FCAS2; OMIM 611762) that belongs to the group of hereditary
recurrent fevers1. The aforementioned Mendelian disorders are
primarily characterized by intermittent episodes of fever and
serosal inﬂammation (including sterile peritonitis, arthritis, and
abdominal pains) that may coincide with myalgia and urticarial
rash. In contrast to most members of the nucleotide-binding
domain leucine-rich repeat proteins (NLR) family, NLRP12 (also
known as NALP12, RNO, MONARCH-1, and PYPAF-7) is
thought to play a suppressive role on inﬂammatory responses.
Indeed, overexpression of FCAS2-causing NLRP12 frameshift
mutations results in unrestrained activation of nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB)1. Besides
this inhibitory role on the canonical NF-κB pathway, biochemical
studies revealed that NLRP12 also negatively interferes with the
proteasome-mediated degradation of NF-κB-inducing kinase
(NIK) through the TNF receptor associated factor 3 (TRAF3) in
human monocytes2,3. Foremost, genetic ablation of Nlrp12 ren-
ders mice highly susceptible to colitis and colitis-associated col-
orectal cancer4,5, while being resistant to Salmonellosis6.
However, the function of NLRP12 on bacterial tolerance and host
defense remains largely unappreciated as mutant animals were
also found highly susceptible to infection by a vaccinated strain of
Yersinia pestis7. Collectively, these paradigms argue for the need
to better understand the complex regulatory mechanisms by
which NLRP12 signaling could mediate tolerance to the gut
microbiota while being exploited by some bacterial pathogens7.
Escherichia coli is a versatile Gram-negative commensal that
typically colonizes the gastrointestinal tract within a few hours
after birth. E. coli successfully exploits several ways to efﬁciently
compete with other microorganisms allowing it to occupy speciﬁc
niches in the gut. Enterohemorragic E. coli (EHEC) and enter-
opathogenic E. coli (EPEC) remains an important cause of diar-
rhea or hemorrhagic colitis in humans worldwide8. Infection by
EPEC and EHEC results in the effacement of the brush border
microvilli followed by bacterial attachment to the apical plasma
membrane of intestinal epithelial cells. Similar to the related
EPEC and EHEC, Citrobacter rodentium is an extracellular
enteric bacterial pathogen that naturally colonizes the caecum
and the colon of mice9. As is observed in humans, C. rodentium
attaches to and colonizes the intestinal epithelium by triggering
the development of lesions and inﬁltration of phagocytic mono-
nuclear cells10. Of note, protective immunity to C. rodentium
involves several Crohn’s disease predisposing genes, among
which are the nucleotide-binding oligomerization domain con-
taining protein 2 (encoded by the NOD2 gene)11 and the
autophagy 16-like 1 (encoded by the ATG16L1 gene). NOD2 is
required for local production of the chemokine CCL2 through the
recruitment of the serine-threonine kinase RIPK2 (also known as
CARDIAK and RIP2)12. Indeed, a prolonged bacterial shedding
in infected Nod2-deﬁcient mice results at least partially from an
impaired recruitment of monocytes11. It is also worth noting that
ATG16L1 was found to interact with NOD213 and to interfere
with poly-ubiquitination of the serine-threonine kinase RIPK214
that is required for NF-κB activation in response to bacterial
muramyl dipeptide (MDP). Consequently, animals that are
hypomorphic for ATG16L1 expression showed enhanced NOD2-
mediated protection against C. rodentium15.
Herein, we report evidence that NLRP12 promotes bacterial
tolerance via degradation of NOD2 through the
Ubiquitin–Proteasome Pathway. This involves sequestration of
the heat-shock protein 90 (HSP90) that is one of the most
abundant molecular chaperone in the cytosol. Loss of HSP90
recruitment results in MDP tolerance through a failure to protect
NOD2 from being degraded by the proteasome16. This loss of
MDP tolerance results in enhanced NOD2-dependent recruit-
ment of inﬂammatory monocytes that is associated with the
induction of several interferon-stimulated genes (ISG), including
IFIT2 that was found to protect from an attaching-and-effacing
bacterial pathogen.
Results
The nucleotide binding structures of NLRP12 bind to NOD2.
Since NLRP12 may potentially interact with both Caspase-
activating recruitment domains (CARDs) of NOD2 but not that
of NOD117, we hypothesized that NLRP12 may promote MDP
tolerance by dissociating the NOD2-HSP90 complex, which is
required for NF-κB activation in response to bacteria16. To this
end, we generated THP-1 cells stably expressing the fusion pro-
tein Myc-BirA*-NOD2. In accordance with yeast two-hybrid
screen data17, we conﬁrmed the NOD2-NLRP12 interaction in
monocytic cell line when speciﬁcally inhibiting the proteasome
degradation of NOD2 that is induced in response to MDP
(Fig. 1a). By contrast, the formation of the NOD2–NLRP12
complex was not observed in response to bacterial lipopoly-
saccharide (LPS) that is neither sensed by NOD2 nor NLRP12
(Fig. 1a and Supplementary Fig. 1). HEK293T cells were next
transfected with plasmids transiently expressing FLAG-tagged
NOD2 and Myc-tagged NLRP12 (Fig. 1b). Overexpression of full-
length FLAG-tagged NOD2 together with Myc-tagged NLRP12
resulted in an interaction with RIPK2, which was under-
represented in the complex at high NLRP12 concentration as
shown by immunoprecipitation using an anti-FLAG antibody
(Fig. 1c). Mapping of the interaction domain from human
NLRP12 further showed that the assembly of a protein complex
with NOD2 involved a linker region of NLRP12 (residues
200–224) in which ATP binding is required for the inhibition to
occur (Fig. 1d)2. By contrast, the N-terminal Pyrin domain of
NLRP12 (residues 1–98) that is required for apoptotic signaling18
was found dispensable for speciﬁcally interacting with NOD2
(Fig. 1d and Supplementary Fig. 2). Together, these results sug-
gested that NLRP12 might interfere with NOD2 signaling in
monocyte-derived cells where NLRP12 is primarily expressed
(Supplementary Fig. 3).
NLRP12 triggers MDP tolerance through degradation of
NOD2. To corroborate the role of NLRP12 as a potential
checkpoint blocker of NOD2 signaling in monocytes, we exam-
ined the inﬂuence of NLPR12 on the stability and the activity of
the NOD2/RIPK2 complex. Co-immunoprecipitation experi-
ments revealed that NLRP12 expression promotes poly-
ubiquitination of the NOD2/RIPK2 complex in HEK293T cells
(Fig. 2a and Supplementary Fig. 4). By contrast, the ubiquitina-
tion status of NOD1 was not inﬂuenced by full-length NLRP12
(Supplementary Fig. 5a). Consistent with a regulation of NOD2
activity at the protein level through its interaction with NLRP12,
blocking of protein neosynthesis using cycloheximide revealed
that NLRP12 expression reduced the half-live of the NOD2
protein (Fig. 2b). This inhibitory effect of NLRP12 on the stability
of NOD2 was compromised upon inhibition of the ubiquitin-
proteasome pathway by MG132 (Supplementary Fig. 5b).
Accordingly, transient expression of full-length human NLRP12
greatly reduced NOD2-mediated p50/p65 reporter activation in
response to MDP in HEK293T cells (Fig. 2c). While increasing
amounts of transfected NLRP12 further reduced MDP-induced
NF-κB activation by about 70% (Fig. 2c), this correlated with the
lowered protein levels of both NOD2 and RIPK2 when NLRP12 is
overexpressed (Fig. 1c). The formation of such protein complexes
between NOD2 and NLRP12 coincided with a greater assembling
of K48 poly-ubiquitin chains on NOD2 when pretreating THP-1
cells stably expressing the fusion protein Myc-BirA*-NOD2 with
the proteasome inhibitor MG132 (Fig. 2d and Supplementary
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Fig. 6 and 7). As reported previously19, co-immunoprecipitation
experiments conﬁrmed an interaction between NOD2 and the
chaperone protein HSP90 in response to MDP that was critical
for the inhibition to occur (Fig. 2d). Indeed, pretreating THP1-
cells with MG132 strongly inhibited the formation of the NOD2/
HSP90 complex in response to MDP, while LPS stimulation
expectedly failed to do so (Fig. 2d). Consequently, NOD2 was
migrating at higher molecular weights (visible as a smear) when
treating THP-1 cells with MDP (Supplementary Fig. 8a). This
correlated with a greater amount of NLRP12 as determined by
western blotting (Supplementary Fig. 8b). Collectively, we iden-
tiﬁed NLRP12 as a NOD2-interacting protein that may promote
degradation of NOD2 through the Ubiquitin–Proteasome Path-
way and subsequently MDP tolerance in monocytes.
NLRP12 deﬁciency impairs MDP tolerance in mice. A lowered
NLRP12 gene expression is observed in patients with septic
shock20, suggesting a potential feedback regulatory loop on
NLRP12 function during sepsis. Indeed, endotoxin treatment
negatively regulates NLRP12 promoter activity in human mono-
cytes through the PR domain zinc ﬁnger protein 1 (PRDM1)21.
Given that knocking-down NLRP12 expression may enhance
TLR4 signaling in vitro3, we next aimed to conﬁrm whether
Nlrp12 expression might indirectly inﬂuence host responsiveness
to bacterial LPS in vivo. To this end, we made use of Nlrp12-
deﬁcient mice that were generated by replacing the second exon
encoding the Pyrin domain of NLRP12 with a neomycin selection
cassette through homologous recombination (Supplementary
Fig. 9). Wild-type and mutant mice were challenged with a lethal
dose of highly puriﬁed LPS from Escherichia coli 0111:B4, as a
model of acute endotoxin septic shock. Unlike Caspase11- and
Tlr4-deﬁcient mice22, no difference in survival of wild-type and
Nlrp12-deﬁcient mice was observed (Fig. 3a). We next tested the
potential role of NLRP12 in the susceptibility of LPS-sensitized
mice to a secondary challenge with MDP23. Wild-type and
Nlrp12-deﬁcient mice were primed with a non-lethal dose of
highly puriﬁed LPS from E coli 0111:B4. As a consequence of a
failure to negatively regulate NOD2 signaling, LPS-primed
Nlrp12-deﬁcient mice were signiﬁcantly more susceptible to sec-
ondary MDP challenge when compared to similarly treated
control animals (Fig. 3b). We next generated mice that are deﬁ-
cient for both Nod2 and Nlrp12 and compared the survival rate of
this compound mutant mice to the one of Nlrp12-deﬁcient mice.
Consistent with our in vitro ﬁndings, a greater survival rate was
observed in animals lacking both NOD2 and NLRP12 (Fig. 3c).
Thus, NLRP12 is dispensable for protecting mice against endo-
toxemia, but rather function as a negative regulator of
NOD2 signaling in mice.
MDP tolerance is lost in monocytes deﬁcient for NLRP12.
Given that unrestrained human NOD2 signaling results in auto-
inﬂammatory syndromes24, we next assessed whether the FCAS2-
causing mutation in the NLRP12 gene may fail to dominantly
repress activation of NF-κB in response to MDP. To this end, we
generated plasmids encoding the most frequent mutations in
NLRP12. Each mutant was transiently transfected in
HEK293T cells together with full-length NOD2. All mutants with
single amino-acid replacements were found to efﬁciently repress
MDP-induced activation of NF-κB (Fig. 4a) and to interact with
HSP90 (Fig. 4b), as observed in cells expressing wild-type
NLRP12. In contrast, the R284X nonsense mutation failed to
inhibit the activation of NF-κB in response to MDP (Fig. 4a) and
of the JAK/STAT pathway by the S/T kinase TANK-binding
kinase 1 that is commonly referred as TBK-1 (Supplementary
Fig. 10). It coincided with a barely detectable recruitment of
HSP90 by such mutation (Fig. 4c) even if this was not related to a
failure of the R284X nonsense mutation to interact with NOD2
(Fig. 4d). As a consequence, loss of NLRP12 expression by
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CRISPR/Cas9-mediated knockout system in human monocytic
THP-1 cells enhanced secretion of TNF-α in response to MDP
when compared to parental cells (Fig. 4e). Likewise, MDP
induced a greater secretion of both tumor necrosis factor alpha
(TNF-α) and interleukin-6 (IL-6) in PBMCs from patients
bearing the R284X nonsense mutation when compared to control
cells (Fig. 4f and Supplementary Fig. 11a-b). This provided a
potential explanation for the loss of tolerance to MDP that
account for the failure to detect the truncated protein in such
mutant cells by western blotting (Supplementary Fig. 11c). The
possibility of a dominant negative effect was further ruled out by
conﬁrming that the protein level of the full-length isoform of
NLRP12 was lowered by about 30% in PBMCs from the twin
patients bearing the R284X nonsense mutation when compared
to control lysates (Supplementary Fig. 11c). Thus, such lack of
MDP tolerance was the consequence of haploinsufﬁciency
resulting from the activation of a surveillance pathway referred to
as nonsense-mediated mRNA decay, which was blocked by
cycloheximide (Fig. 4g). Meanwhile, a greater activation of the
NF-κB transcriptional complex by MDP was observed in
monocytes from the bone marrow of Nlrp12-deﬁcient mice but
not in those from Nlrp12−/−:Nod2−/− mice (Supplementary
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Fig. 12a). Consequently, a greater secretion of both TNF-α and
IL-6 was also detectable in the supernatant of LPS-primed
monocytes that were subsequently treated by MDP (Supple-
mentary Fig. 12b). Likewise, similar ﬁndings were observed in
macrophages that were derived from the bone marrow of Nlrp12-
deﬁcient mice (Supplementary Fig. 12c), even if the difference
was less pronounced when compared to what observed in
monocytes (Supplementary Fig. 12a). A potential explanation for
this difference may result from the down-regulation of NLRP12
during differentiation of monocytes into macrophages21. Collec-
tively, these results suggested that the serosal inﬂammation of
FCAS2 patients might result from an impaired tolerance of
monocytes towards MDP.
NOD2-dependent ISG response in the gut of Nlrp12−/− mice.
We next examined at high-resolution the colon and caecum of
Nlrp12-deﬁcient mice for any spontaneous signs of inﬂammation
as a consequence of an impaired tolerance to MDP derived from
the gut microbiota. To this end, whole-genome expression ana-
lysis was performed on RNA extracted from the caecum of wild-
type and mutant mice. A set of 106 genes were differentially
regulated as a result of NLRP12 deﬁciency, among which 35 genes
were signiﬁcantly up-regulated by at least one log2-fold change in
Nlrp12-deﬁcient mice compared to controls (Supplementary
Data 1). Of these, gene-ontology analysis identiﬁed a signiﬁcant
overrepresentation of ISG (Fig. 5a), including those encoding
interferon-induced protein 44 (IFI44), interferon-induced protein
with tetratricopeptide repeats 2 (IFIT2), Apolipoprotein L9
(APOL9a/b) and 2’-5’-Oligoadenylate synthetase 2 (OAS2).
Transcriptional activation of the promoters of those ISG is
allowed through the binding to Interferon Stimulated Response
Elements (ISRE) of the heteromeric IFN-stimulated gene factor 3
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complex (ISGF3) that is composed of the signal transducer and
activator of transcription 1 (STAT1). In agreement with this, a
tonic activation of the transcription factor STAT1 was observed
in the caecum of Nlrp12-deﬁcient mice when compared to that in
controls (Fig. 5b), while it was lowered in the absence of
NOD2 signaling at steady state (Supplementary Fig. 13a). Con-
sistently, qRT-PCR analysis conﬁrmed a greater expression of the
aforementioned differentially expressed genes (namely Iﬁ44, Iﬁt2,
Oas2, and Apol9a/b) in the caecum from Nlrp12-deﬁcient mice
(Fig. 5c, d), but not in the intestine of either Nlrp12−/−:Nod2−/−
or Nod2−/− mice (Fig. 5e and Supplementary Fig. 13b respec-
tively). Further, the use of the ISRE-luciferase reporter gene assay
led us to reveal that overexpression of NLRP12 signiﬁcantly
lowered the activation of the JAK/STAT signaling pathway by
TBK-1 (Supplementary Fig. 10). To further understand the
sequence of events leading to this robust antiviral response at
baseline, RNA was next extracted from isolated intestinal epi-
thelial cells (IECs) and from lamina propria mononuclear cells
(LPMCs) of wild-type and mutant intestine. In line with previous
ﬁndings, the transcript level of the above-mentioned differentially
expressed genes (including Iﬁ44, Iﬁt2, Oas2, and Apol9a/b) was
primarily enriched in primary IECs isolated from both the colon
and the caecum of Nlrp12-deﬁcient mice (Supplementary
Fig. 14a). Consistently, immunohistochemical analysis revealed
an enhanced production of either IFIT2 or OAS2 that is essen-
tially restricted to the epithelium of the caecum and proximal
colon from Nlrp12-deﬁcient mice (Fig. 5f and Supplementary
Fig. 15). This is in line with the idea that NOD2-mediated
inﬂammasome activation is enhanced by IL-3225, which subse-
quently triggers type I/III interferon (IFN) activation26,27. In
contrast, the transcript levels of numerous genes with ascribed
function on mucosal adaptive immunity (including Ighm, Ptprc,
Anp32a, and Mcpt1) were not signiﬁcantly changed (Supple-
mentary Fig. 14b). To speciﬁcally elucidate the cell type respon-
sible for the negative effect of NLRP12 on the epithelial
expression of IFIT228, we generated bone-marrow chimeras.
While the expression of IFIT2 was barely detectable in the
proximal colon of wild-type chimeric mice (WT→WT) (Fig. 5g),
the intestinal epithelium of Nlrp12-deﬁcient recipients that were
reconstituted with hematopoietic cells from mutant mice
(KO→KO) was characterized by higher protein level of IFIT2
(Fig. 5g) as what observed in non-chimeric mutant mice (Fig. 5f).
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Surprisingly, the epithelial expression of IFIT2 was observed in
wild-type recipients that were adoptively transplanted with leu-
kocytes from Nlrp12-deﬁcient mice (KO→ WT) (Fig. 5g). This
coincided with a lowered abundance of macrophages in the
intestine 8 weeks after reconstitution of wild-type and mutant
recipients with Nlrp12-deﬁcient leukocytes, compared to animals
that received wild-type bone marrow cells (Fig. 5h and Supple-
mentary Fig. 16). By contrast, transfer of wild-type bone marrow
cells into mutant mice (WT→KO) failed to induce epithelial
expression of IFIT2 (Fig. 5g). Similar results were observed in the
caecum of chimeric mice (Supplementary Fig. 16). In accordance
with our data in the model of acute endotoxin septic shock
(Fig. 3), IFIT2 primarily functions as a downstream effector of the
IFN-λ receptor28 that may subsequently inﬂuence the outcome of
Nlrp12-deﬁcient mice in response to endotoxin shock29. While
IFIT2 is thought to regulate cell death and inﬂammation29, epi-
thelial proliferation is also orchestrated by several additional ISG
that were upregulated within the epithelium of Nlrp12-deﬁcient
mice30, such as Apol9a/b31. In this context, it is worth noting that
the effect of IFN alpha/beta on IFIT2 induction is far less com-
partmentalized than the one of the IFN lambda receptor that is
primarily expressed to epithelial cells32. Altogether, the bone
marrow experiments demonstrated that NLRP12 deﬁciency in
leukocytes is responsible for a greater inﬂammatory response
driven by type I/III interferons downstream of NOD2 signaling in
monocytes. This suggested us such epithelial ISG induction is
likely the consequence of greater NOD2-dependent secretion of
type I/III interferons by monocytes that migrate to the tissue from
the bone marrow, but it is still not clear whether it functions
independently.
Loss of NLRP12 improves NOD2-driven colonization resis-
tance. Previous work showed that NOD2 signaling is required for
optimal eradication of C. rodentium33,34, which is a mouse-
restricted model for attaching and effacing (A/E) enteric
bacterial-induced diarrhea such as those caused by EPEC and
EHEC in humans. C. rodentium colonizes the caecum and the
colon of mice through attachment to the epithelium, effacement
of microvilli-covered surface and the formation of pedestal-like
structure9. Given that NLRP12 negatively MDP tolerance by
regulating the stability of NOD2/RIPK2 complex, we next
determined whether loss of NLRP12 may protect mice from C.
rodentium as a potential consequence of a greater epithelial
expression of IFIT211,34. To this end, we orogastrically inoculated
wild-type, Iﬁt2-deﬁcient and Nlrp12-deﬁcient mice with 1 × 109
colony-forming units of C. rodentium. A kanamycin-resistant
strain of C. rodentium was used for non-invasive monitoring of
bacterial growth in the feces. As expected35, a typical bacterial
shedding curve was observed in wild-type mice, however the
intestine of Nlrp12-deﬁcient mice was less rapidly colonized by C.
rodentium (Fig. 6a). In contrast, the peak of bacterial colonization
occurred earlier in Iﬁt2-deﬁcient mice (Fig. 6b) as was observed in
the absence of STAT1 that is required for Caspase11-dependent
inﬂammasome activation in response to C. rodentium36. The
latter results suggested to us that enhanced IFIT2 secretion at
steady state might protect the intestine of Nlrp12-deﬁcient mice
against C. rodentium, which is most likely caused by a loss of
tolerance to MDP. We next compared the colonization dynamic
of C. rodentium in mice that are deﬁcient for both NLRP12 and
NOD2. Similar to Nod2-deﬁcient mice (Supplementary Fig. 17a),
bacterial burden among compound mutant mice was persisting
even 2 weeks post-infection (Fig. 6c). Consistent with a tolero-
genic property of NLRP12 on NOD2 signaling in monocytes,
intraluminal elimination of C. rodentium was improved in leth-
ally irradiated mice that were speciﬁcally engrafted with the bone
marrow cells of Nlrp12-deﬁcient mice although this difference
failed to reach statistical signiﬁcance (Fig. 6d). Conversely, the
colonization resistance was found to be similar in both control
and mutant mice that were reconstituted with wild-type bone
marrow cells (Fig. 6e). To obtain additional evidence that such
colonization resistance result from a loss of MDP tolerance in
monocytes, controls and LysM-Cre;Nod2ﬂ/ﬂ mice, in which Nod2
gene is speciﬁcally deleted in LysM-expressing cells, were orally
infected with C. rodentium for analyzing the intraluminal bac-
terial load. A similar number of the pathogen to what seen in
Nod2-deﬁcient mice was recovered from feces of LysM-Cre;
Nod2ﬂ/ﬂ mice compared to Nod2ﬂ/ﬂ animals and to those that
express the Cre recombinase in IECs (Supplementary Fig. 17b).
Such delayed clearance of C. rodentium from the gut lumen
resulted in a greater bacterial dissemination in the spleen (Sup-
plementary Fig. 17c). This was associated with spenomegaly
(Supplementary Fig. 17d) and tissue pathology as evidenced
respectively by about 47 percent increase in spleen weight (Sup-
plementary Fig. 12d) and by the enhanced histological score
(Supplementary Fig. 17e) and a 30 percent increase in the crypt
length (Supplementary Fig. 17f-g). To further examine the basis
of how NOD2-mediated host defense may protect Nlrp12-deﬁ-
cient mice against C. rodentium, RNA was extracted from the
caecum of infected mice at day 0 and day 7 post-infection and a
genome-wide analysis of the acute transcriptional response to the
pathogen was performed (Supplementary Data 1). As expected, C.
rodentium infection was found to robustly induce expression of
many genes involved in Th1- and Th17-mediated host defense37.
We identiﬁed a set of 551 transcripts whose expression was
modulated at least one log2-fold change in response to the
infection independently of NLRP12 expression (overlapping zone
in Venn diagram; Supplementary Fig. 18a–b). By contrast, the
expression of 427 genes showed a greater degree of change as a
consequence of NLRP12 deﬁciency. Gene ontology analysis of
these 427 differentially expressed genes revealed a signiﬁcant
enrichment of up-regulated molecules that were primarily
assigned to the functional categories of T helper cell differentia-
tion and granulocyte adhesion and diapedesis (Supplementary
Fig. 18c–f). In agreement with these results, the colon lengths of
Nlrp12-deﬁcient mice was signiﬁcantly shortened at day 7 post-
infection when compared to controls (Fig. 6f). An enhanced
luminal level of lipocalin-2 that is primarily secreted by neu-
trophils was subsequently found in the absence of NLRP12 as
early as day 8 after bacterial infection (Fig. 6g). This was corre-
lated with a greater thickening of the colonic mucosa (Fig. 6h)
and with an increased length of the colonic crypts of Nlrp12-
deﬁcient mice (Fig. 6i) that is most likely caused by greater
recruitment of leukocytes in response to the pathogen. To further
explore this possibility, the mononuclear phagocyte system from
the colon of mice was examined in response to the pathogen
(Supplementary Fig. 19). Cytoﬂuorometry analysis conﬁrmed
enhanced accumulation of Ly6ChiMHCIIhiCCR2+ cells within
cell suspensions of the colonic lamina propria of infected Nlrp12-
deﬁcient mice when compared to that in controls on day 4
(Fig. 6j, k and Supplementary Fig. 20). When compared to that in
Nlrp12−/−:Nod2−/− mice, the colon of Nlrp12-deﬁcient mice
showed an increased accumulation of macrophages (265 ± 62 vs.
54 ± 49 of Ly6C-CD64+CD11b+ cells among a pool of 10,000
Lin- MHCII+ mononuclear cells) (Fig. 6l, m) in which NLRP12
has been shown to negatively regulate extracellular signal-
regulated kinases 1 and 2 (ERK1/2) signaling38. This was fol-
lowed by an increased phosphorylation of ERK1/2 as what
observed in response to Salmonella enterica serovar Typhimur-
ium6 (Supplementary Fig. 21a). Such imbalance in the tolerogenic
milieu suggested to us that C. rodentium may exploit
NLRP12 signaling for limiting the accumulation of monocytes
when being recruited at the site of the infection. By contrast, no
change in lipidation of LC3 was observed at either day 7 or 14
post-infection (Supplementary Fig. 21b) and the monocytes iso-
lated from intestine of Iﬁt2-deﬁcient mice showed a similar
MHCII expression with a progressive loss of Ly6C marker when
compared to that in control mice (Supplementary Fig. 22).
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Altogether, these results demonstrated that NOD2 signaling
promotes accumulation of phagocytes to the site of infection in
Nlrp12-deﬁcient mice, which may subsequently contribute to the
improved clearance of C. rodentium39.
Discussion
Herein, we unveil a function of NLRP12 as a checkpoint blocker
of NOD2 signaling in monocytes that is responsible for the
accumulation of inﬂammatory monocytes. Mutational analysis
led us to identify the essential domain (residues 200–224) of
NLRP12 that is interacting with the Crohn’s disease predisposing
NOD2 protein. Consistent with these ﬁndings, our ﬁnding indi-
cated that the nucleotide-bound state of NLRP12 may repress the
stability of NOD2 by sequestrating HSP90 that is required for
stabilizing the NOD2/RIPK2 complex in response to MDP16.
This highly conserved region of NLRP12 may contribute to some
conformational changes of HSP90. It shares similarities with the
ﬁsh-speciﬁc NACHT associated domain (referred as PF14484)
and is responsible for the degradation of NIK2, which is known to
regulate the NOD2-mediated signaling pathway in monocytes40.
Noteworthy, it includes the ATP/GTP-speciﬁc phosphate binding
loop called Walker A and a Mg2+ coordination site called Walker
B. This agrees with previous reports indicating a suppressive
function of ATP-binding domain on the activity of the plant R
protein I-2 that shows similarities with NLRP1241. As a con-
sequence of its interaction with NLRP12, NOD2 was ubiquiti-
nated and the NOD2/RIPK2 complex showed lowered stability
in vitro. Such non-resolving inﬂammatory conditions result in
protective immunity against an enteric bacterial pathogen,
although it is unclear whether this reﬂects an improved NOD2-
dependent survival of newly extravasated blood monocytes.
Further, we provide evidence that NLRP12 signaling within the
hematopoietic compartment is exploited by C. rodentium in mice
as what observed with Salmonella enterica serovar Typhimur-
ium34. This agrees with a recent report showing enhanced
NOD2-mediated protective immune response against C. roden-
tium in animals that are hypomorphic for Atg16L1 protein
expression15. Such paradigm may reﬂect a potential selective
advantage of disease-causing NLRP12 mutations against some
enteric bacterial infections as a consequence of a loss of MDP
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tolerance. Thus, our studies could help to explain the recurrent
episodes of serosal inﬂammation (including peritonitis and
abdominal pains) that are triggered by exposure to cooling
temperatures or cold in patients bearing non-sense mutations in
the NLRP12-encoding gene1. Ultimately, our ﬁndings could lead
to new strategies for improving disease tolerance in patients with
NLRP12 mutations through modulation of NOD2-mediated
control of the intestinal permability and the gut microbiota42
that are regulating the body's energy expenditure. Indeed, changes
in the composition of the gut microbiota contribute to the sus-
ceptibility of colitis that is caused by NLRP12 deﬁciency43.
Alternatively, one may also consider that loss of NLRP12 may
inﬂuence the persistence of some viruses (e.g., Norovirus) as a
consequence of the greater epithelial expression of several ISG,
including IFIT2 that is involved in antiviral immunity and
OAS2 as a RNA-binding protein that interacts with NOD244.
Thus, the exact role of NLRP12 signaling on NOD2-mediated
resilience of the gut microbiota now deserves further experi-
mental studies with littermate controls and co-housed mice. In
this context, we are currently investigating the cause of such
inﬂux of inﬂammatory monocytes that correlated with ISG
induction within the epithelium of Nlrp12-deﬁcient mice. Col-
lectively, we provide the rational for targeting therapeutically
NOD2 signaling in familial cold auto-inﬂammatory syndrome by
unveiling an unappreciated molecular link with the pathogenesis
of Crohn’s disease.
Methods
Mice. Nlrp12-deﬁcient (Nlrp12−/−) mice were generated through homologous
recombination by using the Lex-1 ES cells that are derived from the 129SvEvBrd
strain (Supplementary Fig. 9a). A gene-targeting vector with a neomycin-resistance
cassette was constructed to replace the ﬁrst two exons of Nlrp12. The latter is
required to encode the Pyrin domain of NLRP12, which is essential for recruiting
ASC and subsequently for activating Caspase-1. Genotyping of positive ES clones
was accomplished by Southern blotting analysis. Nlrp12−/− mice were produced at
the expected Mendelian ratio by crossing heterozygous animals and were crossed
with Nod2-deﬁcient mice12 for generating animals that are deﬁcient for both
NOD2 and NLRP12. Genotyping of mouse tail DNA was performed to conﬁrm the
presence of the wild-type and/or targeted alleles (Supplementary Fig. 9b). The
absence of Nlrp12 mRNA in Nlrp12−/− animals was conﬁrmed by quantitative
reverse-transcriptase (RT)-qPCR (Supplementary Fig. 9c). Nlrp12-deﬁcient (Nlrp12
−/−) mice were backcrossed onto a C57BL6/J background. Iﬁt2-deﬁcient (Iﬁt2−/−)
were generated as described elsewhere and backcrossed onto a C57BL/NCrl
background (N10)29. All animal studies were approved by the local investigational
review board. Animal experiments were performed in an accredited establishment
(N° B59-108) according to governmental guidelines N°86/609/CEE. Age- and
gender-matched animals were housed up to ﬁve per cages and had free access to a
standard laboratory chow.
Bacterial infection. Age and sex-matched mice were orally inoculated with ~1 ×
109 CFU of either Citrobacter rodentium strain DBS100 or kanamycin-resistant C.
rodentium strain DBS120 for colony forming unit (CFU) counting in feces (kindly
provided by D. Schauer, Massachusetts Institute of Technology). Histological
scoring of inﬂammatory cells inﬁltration and of crypt length damage was blindly
performed on hematoxylin and eosin (H&E) stained sections by two investigators.
Bone marrow transplantation experiments. Recipient mice underwent a lethal
total-body irradiation. Twenty-four hours post-irradiation, mice received intrave-
nously 5 × 105 fresh bone marrow cells. Blood was collected in heparin-containing
tubes 7–8 weeks after bone-marrow transplantation and reconstitution efﬁciency
was checked by ﬂow cytometry using a FACS Canto II (BD biosciences) after cell
staining by PE- conjugated anti-CD45.1 (A20) and FITC- conjugated anti-CD45.2
(104) from BD biosciences. Two months after bone-marrow transplantation, the
colonization resistance towards C. rodentium and the waterfall-shaped ﬂow cyto-
metric distribution of monocyte descendants was analyzed within the colon of
chimeric mice.
Septic shock. Male mice (8–10 weeks old) were injected intraperitoneally with a
non-lethal dose of highly puriﬁed LPS (10 mg/kg of highly puriﬁed E. coli 0111:B4
purchased from Invivogen) 24 h before a secondary challenge with murabutide at
10 mg/kg (Invivogen). Alternatively, mice were challenged with a lethal dose of
highly puriﬁed LPS as a model of acute endotoxin septic shock (54 mg/kg of highly
puriﬁed E. coli 0111:B4 purchased from Invivogen). Mice were monitored twice
daily over a 6-day period. The morphology of recruited cells within the peritoneum
of mice was determined by cytological examination after centrifugation on glass
microscope slides (Cytospin; Shandon), ﬁxation and staining according to the
manufacturer's recommendations (Diff; Dade Behring Inc.). For cytokine mea-
surements, serum was taken at 90, 180, 360, and 540 min after secondary MDP
challenge.
Immunoprecipitations. In all, 2.5 × 106 HEK293T cells were transfected with the
indicated constructs using Lipofectamine2000 (Invitrogen), as indicated in the
manufacturers’ protocol. Cells were harvested in RIPA buffer 24 h post transfection
(150 mM NaCl, 50 mM Tris pH 7.4, 1% Triton X-100, 0.1% SDS, 0.5% Na-deox-
ycholate) containing phosphatase inhibitors (20 M β-glycerophosphate, 5 mM NaF,
100 mM Na3VO4) and protease inhibitors (Complete protease inhibitor cocktail
with EDTA; Roche). The lysate was cleared 20 min at 14,000 × g for 20 min and
FLAG-tagged NOD2 was subsequently precipitated for 3 h at 4 °C using anti-FLAG
M2 agarose (Sigma-Aldrich). Proteins were separated by Laemmli SDS-PAGE and
visualized using either anti-FLAG M2 mouse antibody (Stratagene, #200471,
1:2000) or anti-Myc mouse antibody 9E10 (Roche, Cat. No. M4439, 1:1000) or
anti-cMYC rabbit antibody (Santa Cruz, sc-789, 1:1000).
CRISPR/Cas9 gene editing. The NOD2 (NP_001280486) and NLRP12
(NM_001277126) loci were deeply examined; a common translational start for all
the reported isoforms were selected and used to generate KO CRISPR guide RNA
pairs. The gRNAs were subsequently identiﬁed using the Sanger Centre CRISPR
webtool (http://www.sanger.ac.uk/htgt/wge/ﬁnd_crisprs). The chosen gRNAs were
designed to cut as far upstream as possible to generate indels in the region con-
taining the ATG start codon; an additional G were added to the 5′ end of the guides
to maximize expression from the U6 promoter. Complementary oligos were
designed and annealed to yield dsDNA inserts with compatible overhangs to
BsmBI-digested vectors45, the sense guides were inserted into the puromycin
selectable plasmid LentiCRISPR/Cas9v2 (Addgene #52961). HEK293FT cells were
co-transfected with the appropriate Lentivirus plasmids. Following 24 h of recovery
and a further 48 h of puromycin selection (2 μg/mL), cells were subjected to a
further round of puromycin selection to enrich for transfectants. THP-1 cells were
infected with the produced lentivirus harboring the gRNA and the Cas9 protein.
The cell pools were subsequently single cell sorted by FACS and clones analyzed for
NLRP12 or NOD2 depletion by immunoblotting and sequenced. Brieﬂy, genomic
DNA was isolated from cell candidates and the region surrounding the ATG start
codon of both NOD2 and NLRP12 were ampliﬁed by PCR using a forward and a
reverse primer (i.e., indel primers). The resulting PCR products were subcloned
into the holding vector pUC19 and around 10 colonies were picked for each clonal
line. Plasmid DNAs were isolated and sent for sequencing with primers M13F and
M13R to ﬁnally select a cell line. The absence of the NOD2 or NLRP12 protein was
conﬁrmed by western-blotting.
Generation of THP1 cells stably expressing NOD2. The stable THP-1 cell line
was generated using a retroviral system. The Myc-BirA*-NOD2 was constructed
using the pLXN-retroviral vector (ClonTech, USA). The retrovirus vector was
transfected into HEK293-FT cell line for the production of viruses. The viruses
were harvested after 72 h and the THP-1 cells were infected and subsequently
selected using 250 µg/mL of Geneticin® (LifeTechnologies, USA). After 14 days, the
surviving cells were cell sorted and individual clones were grown for 2 months. The
individual clones were tested for the proper expression of Myc-BirA*-NOD2 using
the anti-NOD2 (2D9) monoclonal antibody (SantaCruz, sc-56168, 1:250).
Luciferase reporter assays. The NLRP12 coding sequence was inserted into the
pcDNA3.1 vector and site-directed mutagenesis was performed to generate the
plasmids expressing the Arg284X and Arg352Cys mutations. 3 × 104
HEK293T cells were seeded in a 96-well format directly prior transfection with the
indicated amounts of plasmid using XtremeGene9 (Roche) as indicated in the
manufacturers’ protocol. Cells were harvested in luciferase lysis buffer 24 h post
transfection (25 mM Tris pH 8, 8 mM MgCl2, 1% Triton, 15% glycerol, 1 mM
DTT) and luciferase activity was measured using a standard plate luminometer
(Berthold Instruments). Luciferase activity was normalized as a ratio to β-
galactosidase activity and standard deviation (SD) was calculated from triplets.
Analysis of human peripheral mononuclear cells. Patients with hereditary
recurrent fever carrying the non-sense c.850 C>T (p.R284X) heterozygous muta-
tion in NLRP12 were previously described1. The blood from patients and controls
was collected in citrate collection tubes. PBMCs were isolated by centrifugation
using Ficoll-Paque (GE Healthcare Life Sciences). Fresh cells were stimulated with
Ultrapure LPS (10 ng/mL; Sigma-Aldrich), MDP (10–100 µg/mL; Invivogen),
MDP-DD (10–100 µg/mL; Invivogen), or left unstimulated for 24 h. Supernatants
were collected for ELISA analysis. The treatment with 30 μg/mL of cycloheximide
(Sigma-Aldrich) for 2 h was performed on 5 million PBMCs that were isolated
from fresh blood of the two affected patients using Pancoll gradient centrifugation
(BioTech) and cultured in RPMI 1640 medium.
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Flow cytometry analysis. Cells were stained and analyzed using a FACS
LSRFortessaTM system (BD Biosciences). Dead cells were excluded with the LIVE/
DEAD Fixable Violet Dead Cell staining kit (Life technologies). Lineage-positive
cells were excluded using the PerCP5.5-conjugated anti-CD3 (17A2), anti-NK1.1
(PK136), anti-CD19 (6D5), anti-Ly6G (1A8) (Biolegend). PerCP-conjugated anti-
CCR3 (83103) added to the lineage staining to exclude eosinophils was from R&D.
Allophycocyanin-Cy7-conjugated anti-CD11b (M1/70), PerCP5.5-conjugated anti-
Ly6G (1A8), Brilliant violet 510-conjugated anti-MHC Class II (I-A/I-E) (M5/
114.15.2) and FITC-conjugated and Alexa Fluor 700-conjugated anti-Ly6C (AL21)
were from BD Pharmingen. Allophycocyanin-conjugated anti-CD11c (HL3), PE-
conjugated and APC-conjugated anti-CD64 (X54-5/7.1), Alexa-Fluor 700-con-
jugated anti-MHC Class II (I-A/I-E) (M5/114.15.2), PECF594-conjugated anti-
CD11c (HL3), Brilliant Violet 570-conjugated anti-Ly6G (1A8), Allophycocyanin-
conjugated anti-CD64 (X54-5/7.1), PE Cy7-conjugated anti-CD24 (M1/69), Bril-
liant violet 650-conjugated anti-CD45.2 (104) and Brilliant violet 711-conjugated
anti-CD45.1 (A20) were all from Biolegend. PE-conjugated anti-CCR2 (475301)
was from R&D systems. The data were analyzed using the FlowJo software (Tree
Star).
Cytokine measurement. Cytokine levels were determined by ELISA kits,
according to protocols provided by R&D Systems.
Microarray and gene-ontology analysis. Caecum specimens from non-infected
and infected wild-type and Nlrp12−/− animals were dissected out and stored at
−80 °C in RNAlater® (Ambion, Applied Biosystems, Foster City, CA), until
extraction of total RNA accordingly to manufacturer’s instructions (Qiagen). The
quality of the extracted RNA was conﬁrmed by Agilent 2100 Bioanalyzer using
RNA Nano 6000 (Agilent Technologies). The 4x44K Whole Mouse Genome Oligo
Microarrays (Agilent Technologies) was used to determine the gene expression
proﬁle of two biological replicates. For each labeling, 2 µg of total RNA per sample
were engaged in the synthesis of a ﬂuorescent probe labeled with Cy5 or Cy3
ﬂuorophores. A 2 × 2 factorial experimental design and a dye-swap strategy were
used (GEO accession number GSE59940). After a within array loess normalization,
raw data were analyzed with the LIMMA package and sets of differentially
expressed genes were ﬁltered for a p-value <0.01 and a limit log fold change >1 by
using moderated t-statistic with empirical Bayes shrinkage of the standard errors.
Statistics were corrected for multiple testing using False Discovery Rate approach.
A gene-ontology analysis using Panther was next performed on up- and down-
regulated genes that are referred in Unigene (http://www.pantherdb.org/).
Gene expression analysis. Isolated RNA was reverse-transcribed with the High-
Capacity cDNA Archive kit (Applied Biosystems), according to the manufacturer’s
instructions. The resulting cDNA (equivalent to 5 ng of total RNA) was ampliﬁed
using the SYBR Green real-time PCR kit and detected on a Stratagene Mx3005P
(Agilent Technologies). RT-PCR was performed with the forward and reverse
primers (sequences available upon request) that were designed using Primer
express software, version 1.0 (Applied Biosystems, Foster City, CA). On completion
of the PCR ampliﬁcation, a DNA melting curve analysis was carried out in order to
conﬁrm the presence of a single and speciﬁc amplicon. Actb was used as an internal
reference gene in order to normalize the transcript levels. Relative mRNA levels
(2−ΔΔCt) were determined by comparing (a) the PCR cycle thresholds (Ct) for the
gene of interest and Actb (ΔCt) and (b) ΔCt values for treated and control groups
(ΔΔCt). RNA extraction from whole peripheral blood from controls and FCAS2
patients that were collected in PAXgene tubes was performed using PAXgene
Blood RNA Kit following the manufacturer’s instructions (Qiagen). RNA extrac-
tion from PBMCs was performed using the RNeasy Mini Kit (Qiagen) including
DNase treatment according to the manufacturer’s instructions. One µg of RNA was
reversed transcribed in the presence of 2.5 mM of oligo-dT using the Reverse
Transcriptor kit (Roche) following the manufacturer’s instructions. 75 ng of
cDNAs were ampliﬁed using Q5 High-Fidelity 2X Master Mix (New England
BioLabs). Forward and reverse primers used in PCR ampliﬁcation are located in
the 5’UTR and 3’UTR of NLRP12 cDNA respectively (Sequences available upon
request), which can amplify the two alleles of NLRP12 in the patients and the
healthy donor. Exon 3 of NLRP12 cDNA was sequenced with the Big Dye Ter-
minator sequencing kit (Applied Biosystems) using two different primers
(sequences available upon request), and run on an ABI 3730 × l automated
sequencer. Sequences were analyzed with SeqScape software (Applied Biosystems).
Assembling of K48 poly-ubiquitin chains on NOD2. Assembling of K48 poly-
ubiquitin chains on NOD2 in response to MDP was monitored over time. THP-1
Myc-BirA*-NOD2 cells were pre-treated for one h with DMSO (vehicle) or MG132
(at 12.5 µM) before 10 µg/mL of MDP (InvivoGen, France) was added. At given
time points, samples were taken, spun down and the reaction was stopped using
RIPA lysis buffer plus protease and phosphate inhibitors (ROCHE, Germany).
Additionally, 50 mM of N-ethylmaleimide (Thermoﬁsher scientiﬁc, USA) was
added to the RIPA buffer to lyse the MG132-treated samples. A SDS gel was run
and membranes were blotted against the anti-NOD2monoclonal antibody (2D9)
(SantaCruz, sc-56168, 1:250) and RIPK2 (Cell Signalling Technology, USA) and
anti-actin (Sigma Aldrich, UK, Cat No. A5060, 1:2000) or anti-Tubulin (Sigma
Aldrich, UK, Cat No. T9026, 1:2000) as a controls. NOD2 ubiquitination was
assessed using the anti-poly-K48 antibody (Merck Millipore, USA, Cat No. 05-
1307, 1:2500).
Ubiquitination analysis. The THP-1 Myc-BirA*-NOD2 stable cell line was grown
and a total of 1 × 107 of cells were used for these experiments. Cells were incubated
for 2 h with MDP (10 µg/mL). After the 2 h incubation with and without protea-
some inhibitor MG132 (12.5 µM), the cells were placed on ice, washed twice with
PBS, spun down and incubated in 1 mL of lysis buffer (50 mM HEPES pH 7.5; 150
mM NaCl; 1× complete-EDTA free protease inhibitor; 1X phosphatase inhibitor;
1% iGPAL and 1mM PMSF). Samples were incubated for 10 min and then spun
down at 14,000 × g for 20 min at 4 °C. The Supernatant was separated and incu-
bated with anti-Myc magnetic beads (Thermoﬁsher, UK) for 3 h. Beads were
washed 5 times using the lysis buffer before they were eluted with a 0.1 M Glycine
solution pH 2.0. Finally, 15 µL were loaded onto the gel and immunoblotted using
the monoclonal anti-poly-K48 antibody (Merck Millipore, USA, Cat No. 05-1307,
1:2500) or the monoclonal anti-NOD2 (2D9) antibody (SantaCruz, sc-56168,
1:250).
Statistics. Data were analyzed using Prism4.0 (GraphPad Software, San Diego,
CA). The non-parametric Kruskal–Wallis test with Dunn's multiple comparison
test or the parametric one-way ANOVA test with Bonferroni's multiple compar-
ison test were used. Values represent the mean of normalized data ± SEM. Asterisk,
signiﬁcant difference P < 0.05.
Data availability
The microarray data have been deposited under GEO accession number
GSE59940. A reporting summary for this Article is available as a Supplementary
Information ﬁle.
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